Cargando…
An engineered concealed IL-15-R elicits tumor-specific CD8(+)T cell responses through PD-1-cis delivery
Checkpoint blockade immunotherapy releases the inhibition of tumor-infiltrating lymphocytes (TILs) but weakly induces TIL proliferation. Exogenous IL-15 could further expand TILs and thus synergize with αPD-L1 therapy. However, systemic delivery of IL-15 extensively expands peripheral NK cells, caus...
Autores principales: | Shen, Jiao, Zou, Zhuangzhi, Guo, Jingya, Cai, Yueqi, Xue, Diyuan, Liang, Yong, Wang, Wenyan, Peng, Hua, Fu, Yang-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521244/ https://www.ncbi.nlm.nih.gov/pubmed/36165896 http://dx.doi.org/10.1084/jem.20220745 |
Ejemplares similares
-
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
por: vom Berg, Johannes, et al.
Publicado: (2013) -
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
por: Huntington, Nicholas D., et al.
Publicado: (2009) -
IL-7 and IL-15 independently program the differentiation of intestinal CD3(−)NKp46(+) cell subsets from Id2-dependent precursors
por: Satoh-Takayama, Naoko, et al.
Publicado: (2010) -
The Involvement of Interleukin (IL)-15 in Regulating the Differentiation of Granulated Metrial Gland Cells in Mouse Pregnant Uterus
por: Ye, Weiguo, et al.
Publicado: (1996) -
Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo
por: Gao, Xin, et al.
Publicado: (2013)